MedPath

Induction of true remission in early poor prognosis (erosive) rheumatoid arthritis (RA) - a randomised study of methotrexate and intra-articular corticosteroids or placebo

Completed
Conditions
Early rheumatoid arthritis
Musculoskeletal Diseases
Rheumatoid arthritis
Registration Number
ISRCTN14554919
Lead Sponsor
Arthritis Research Campaign (ARC) (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
82
Inclusion Criteria

1. All patients to meet the American College of Rheumatology criteria for RA
2. Poor prognosis disease according to criteria based on the presence of factors known to be predictive of poor long-term outcome
3. Adequate contraception a prerequisite

Exclusion Criteria

Not provided at time of registration

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath